BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AngioChem Receives Innovation Award from the National Brain Tumor Society for Advancing the Development of Novel Brain Cancer Treatments


2/15/2011 9:57:22 AM

MONTREAL and WATERTOWN, Mass.--(BUSINESS WIRE)--Angiochem, Inc., a clinical stage biotechnology company, and the National Brain Tumor Society (NBTS), a leading U.S. non-profit organization in the brain tumor community, today announced that Angiochem has been presented with the Innovation Recognition Award from the National Brain Tumor Society for its progress in developing novel treatments for brain tumors that are capable of crossing the blood-brain barrier. The NBTS Innovation Recognition Award acknowledges catalytic research projects that will significantly move forward the field of brain tumor research.

Read at BioSpace.com

AngioChem
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES